ROCK & ASSOCIATES for WELLNESS PHARMACY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the NASEM report to the FDA on compounded bioidentical hormones, and on the implementation of the MOU under section 503A of the FDCA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Pharmacy PHA
Issues related to the federal regulation of compounding pharmacy. No specific legislation at this time.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Budget/Appropriations BUD
Appropriations and report language related to the funding of FDA as it affects compounding pharmacies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.